Outcome of relapsed or refractory acute myeloid leukemia treated with intensive salvage chemotherapy in real life in comparison to intermediate dose cytarabine in phase 3 studies

Acute myeloid leukemia (AML) patients unable to achieve a complete response (CR) with standard induction therapy (refractory AML) or whose disease relapses after achieving remission (relapsed) are ...